These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 483950)

  • 1. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of missed abortion, intrauterine death and hydatidiform mole using prostaglandin E2.
    Murray CP; Clinch J
    Ir Med J; 1975 Mar; 68(6):133-5. PubMed ID: 1120656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
    Arshat H
    Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of uterine activity after vaginal administration of prostaglandins.
    Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
    Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R; Grimes DA
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral prostaglandin E2 and amniotomy for induction of labor.
    Craft I
    Adv Biosci; 1973; 9():593-8. PubMed ID: 4805874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy.
    Calder AA; Mackenzie IZ; Embrey MP
    J Reprod Med; 1976 May; 16(5):271-5. PubMed ID: 933106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
    Heinzl S
    Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
    Ekman G; Forman A; Ulmsten U; Wingerup L
    Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.